247 related articles for article (PubMed ID: 12136254)
1. A reassessment of bone scintigraphy and commonly tested pretreatment biochemical parameters in newly diagnosed osteosarcoma.
Stokkel MP; Linthorst MF; Borm JJ; Taminiau AH; Pauwels EK
J Cancer Res Clin Oncol; 2002 Jul; 128(7):393-9. PubMed ID: 12136254
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma.
Franzius C; Bielack S; Flege S; Sciuk J; Jürgens H; Schober O
J Nucl Med; 2002 Aug; 43(8):1012-7. PubMed ID: 12163625
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m-MDP scintigraphy and long-term follow-up of treated primary malignant bone tumors.
Van Laere K; Casier K; Uyttendaele D; Mondelaers W; De Sadeleer C; Simons M; Dierckx R
J Nucl Med; 1998 Sep; 39(9):1563-9. PubMed ID: 9744344
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
[TBL] [Abstract][Full Text] [Related]
5. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate.
Hoefnagel CA; Bruning PF; Cohen P; Marcuse HR; van der Schoot JB
Diagn Imaging; 1981; 50(5):277-84. PubMed ID: 6457735
[TBL] [Abstract][Full Text] [Related]
6. Intense uptake of Tc-99m HMDP in pleural metastasis from osteosarcoma.
Biyi A; Doudouh A; Albouzidi A; Zekri A
Clin Nucl Med; 2006 Jul; 31(7):423-4. PubMed ID: 16785816
[No Abstract] [Full Text] [Related]
7. Prognosis of primary osteosarcoma.
Hamscho N; Grünwald F
J Nucl Med; 2003 Jun; 44(6):996-7; author reply 997. PubMed ID: 12791834
[No Abstract] [Full Text] [Related]
8. Age- and sex-related bone uptake of Tc-99m-HDP measured by whole-body bone scanning.
Brenner W; Sieweke N; Bohuslavizki KH; Kampen WU; Zuhayra M; Clausen M; Henze E
Nuklearmedizin; 2000 Aug; 39(5):127-32. PubMed ID: 10984888
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of bone scintigraphy with SPECT images for detection of pulmonary metastases from osteosarcoma.
Pevarski DJ; Drane WE; Scarborough MT
AJR Am J Roentgenol; 1998 Feb; 170(2):319-22. PubMed ID: 9456937
[TBL] [Abstract][Full Text] [Related]
10. The correlation of Tc-99m MIBI scintigraphy and histological response in determining the percentage of tumor necrosis in osteosarcoma after preoperative chemotherapy.
Punyaratabandhu T; Wittayawongsaruji S; Rajchadara S; Thanakit V; Charoenvareekul S; Khunkitti N; Songpatanasilp T
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S53-62. PubMed ID: 16862675
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
Ann Surg Oncol; 2008 Mar; 15(3):906-14. PubMed ID: 18163171
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
[TBL] [Abstract][Full Text] [Related]
13. Conventional 99mTc-(hydroxy) methylene diphosphate remains useful to predict osteosarcoma response to neoadjuvant chemotherapy: Individual patient data and aggregate data meta-analyses.
Kubo T; Furuta T; Sakuda T; Ochi M; Adachi N
Medicine (Baltimore); 2018 Dec; 97(51):e13308. PubMed ID: 30572434
[TBL] [Abstract][Full Text] [Related]
14. Dynamic bone scintigraphy for evaluation of tumor response after preoperative chemotherapy. A retrospective study of osteosarcoma and Ewing's sarcoma patients.
Winderen M; Stenwig AE; Solheim OP; Saeter G; Aas M
Acta Orthop Scand Suppl; 1999 Jun; 285():11-7. PubMed ID: 10429616
[No Abstract] [Full Text] [Related]
15. [Massive skeletal metastasis: difficulties of bone scintigraphy, contribution of medullary scintigraphy].
Blocklet D; Schoutens A
Rev Med Brux; 1999 Apr; 20(2):A104-5. PubMed ID: 10335106
[No Abstract] [Full Text] [Related]
16. [Survival analysis and the effects of prognostic factors in patients treated for osteosarcoma].
Ozger H; Eralp L; Atalar AC; Toker B; Ayan I; Kebudi R; Bağbek S; Başaran M; Ağaoğlu F; Dizdar Y; Bilgiç B
Acta Orthop Traumatol Turc; 2007; 41(3):211-9. PubMed ID: 17876121
[TBL] [Abstract][Full Text] [Related]
17. Tl-201 and Tc-99m HMDP scintigraphic findings in extraskeletal osteosarcoma.
Kajihara M; Sugawara Y; Miki H; Mochizuki T; Kidani T; Sakayama K
Clin Nucl Med; 2005 May; 30(5):356-8. PubMed ID: 15827415
[TBL] [Abstract][Full Text] [Related]
18. The value of pretreatment clinical and biochemical parameters in patients with newly diagnosed untreated prostate carcinoma and no indications for bone metastases on the bone scintigram.
Stokkel M; Zwinderman A; Zwartendijk J; Pauwels E; van Eck-Smit B
Eur J Nucl Med; 1997 Oct; 24(10):1215-20. PubMed ID: 9323261
[TBL] [Abstract][Full Text] [Related]
19. Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99m skeletal angioscintigraphy.
Ongolo-Zogo P; Thiesse P; Sau J; Desuzinges C; Blay JY; Bonmartin A; Bochu M; Philip T
Eur Radiol; 1999; 9(5):907-14. PubMed ID: 10369989
[TBL] [Abstract][Full Text] [Related]
20. Radionuclide bone scanning of osteosarcoma: falsely extended uptake patterns.
Chew FS; Hudson TM
AJR Am J Roentgenol; 1982 Jul; 139(1):49-54. PubMed ID: 6283871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
